Mian OY

No ORCID on file · 1 paper in corpus · active 2018
2018
NPJ precision oncology ·doi:10.1038/s41698-018-0060-3

There has been little progress in the use of patient-derived xenografts (PDX) to guide individual therapeutic strategies. In part, this can be attributed to the operational challenges of effecting successful engraftment and testing multiple…